EVALUATION OF INFLAMMATION PARAMETERS IN COMPLETE BLOOD COUNT IN PATIENTS DIAGNOSED WITH VESTIBULAR MIGRAINE
Source : https://www.kbb-forum.net/journal/text.php?&lang=en&id=537
Although various studies investigated the role of inflammation in migraine's pathophysiology, the importance of inflammation in VM has been studied in a very few reports [ 1, 6, 9, 20-...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC5yrVestibular migraine is so difficult to treat at times and can take years to diagnose.
Long-Term Efficacy and Safety of Erenumab
Source : https://n.neurology.org/content/early/2021/04/28/WNL.0000000000012029.abstract
Objective To report the efficacy and safety of erenumab among episodic migraine (EM) patients who were unsuccessful on 2-4 preventive treatments observed at week 64 of Open-Label Extension Phase (OLEP)...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC5yrThis is encouraging information.
Recent refractory migraine patient
resistant to tryptans had great success with aimivog
She is able not to miss out on daily
activities
-
Huma Sheikh, CEO, NY Neurology Medicine, PC5yrIf Aimovig is helping than as an abortive, NSAID's or cGRP antagonists would be an option.
Time lost due to an attack - a novel patient-reported outcome measure for acute migraine treatments - Heiko Pohl, Silvia Benemei, David Garcia-Azorin, Joanna Dixon, Elizabeth Huzzey, Michel D Ferrari, 2021
Source : https://doi.org/10.1177/03331024211006048
We propose a new outcome measure to assess the efficacy of migraine treatments translating the approach of the Global Burden of Disease studies from a societal to an individual level:...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC5yrwe need more patient centered outcomes for our studies.
Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study
Source : https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-021-01238-2
Background Migraine is one of the leading causes of disability worldwide. Erenumab is a fully human monoclonal antibody that targets the calcitonin gene-related peptide (CGRP) receptor. This study aimed to...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC5yrThis is great to see that this medication does help decrease abortive use.